Titan Medical Inc (TMDIF)

[pointofreturn]

Just relax and stay calm. The PPS volatility is frustrating, but I look at this big picture, and ultimately within a relatively short period of time I see Titan easily as a $1 billion company.

I look at this as perhaps our last opportunity to accumulate before a steady stream of news – FDA submission, Alpha Prototype completion, US road show and marketing efforts, tissue validation study, CE mark application/approval followed by limited commercial European release, human trials in the US, FDA 510(k), commercialization.

I can’t say for certain when the selling will dry up, or how low we’ll go. But this is an opportunity to build another base of new investors and for ourselves to add cheapies to our own portfolios.
More and more people are hearing about Titan’s robotic surgery technology every day. CNN had a feature on the class-action lawsuit against Intuitive the other day. They just had a terrible last quarter. More and more stories like the anecdote John told. Transenterix has a competitive price point, but a far inferior product technologically.

Titan is going to displace these competitors and capture a significant portion of the market share. Go back and look at my posts on the market – the metrics are extremely impressive and compelling. I underestimated the extent of their reach for placement of the SPORT unit.

It’s just a matter of time. The fact that management has continued to meet targets is extremely encouraging, and I feel very good after spending the afternoon at the AGM that with John being in charge of Titan we are in good hands.

Long and strong.